top of page

Research notes from Dr. Miyamoto

We are pleased to let you hear Dr. Sayuri Myiamoto present her preliminary work, listen to the video. There is a lot more to learn, and her lab is working on the next steps. She is publishing her novel data, we will let you know when the manuscript finishes and in the review process. A part of her work is testing ALS patients for the novel lipid markers they have identified. Although the lipid marker isn't specific for ALS, once ALS is diagnosed, it may be a prognostic marker.

We are hopeful that finding treatments that can modify (increase) this marker in a person the drugs would bring benefit to ALS patients, perhaps slowing disease progression.

14 views0 comments

Recent Posts

See All

Neurodegenerative disease research is pleased to announce the progress of developing TVALA for the treatment of neuroinflammation in ALS. You can read about the trial and follow our progress .

bottom of page